| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 11 | -277,574 | 100% | $38.90 | -$10,796,832 |
| Net | -11 | -277,574 | -100% | -$10,796,832 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Marc Stapley | Chief Executive Officer, Director | $15,085,374 | -$2,351,064 | -13% | 02 Dec 2025 |
| Bonnie Anderson | Director | $5,581,544 | 02 Jun 2023 | ||
| Rebecca Chambers | Chief Financial Officer | $5,173,609 | -$932,064 | -15% | 02 Dec 2025 |
| Tina Susan Nova | President, CLIA U.S. | $4,779,054 | 03 Mar 2022 | ||
| Phillip G. Febbo | Chief Scientific & Med Officer | $4,130,673 | -$568,722 | -12% | 02 Dec 2025 |
| John Leite | Chief Commercial Officer-CLIA | $3,901,188 | -$795,467 | -17% | 02 Dec 2025 |
| Annie McGuire | SVP, General Counsel | $2,959,756 | -$980,108 | -25% | 16 Dec 2025 |
| ROBERT S. EPSTEIN | Director | $2,190,405 | -$753,204 | -26% | 01 Oct 2025 |
| Giulia C. Kennedy | Chief Scientific & Med Officer | $1,750,844 | 06 Dec 2022 | ||
| Jonathan Wygant | VP, Chief Accounting Officer | $1,727,307 | -$449,907 | -21% | 02 Dec 2025 |
| Eliav Barr | Director | $1,578,668 | 18 Jun 2025 | ||
| EVAN/ FA JONES | Director | $1,475,419 | -$2,001,863 | -58% | 25 Nov 2025 |
| JOHN L. BISHOP | Director | $1,277,388 | 17 Jul 2023 | ||
| Muna Bhanji | Director | $1,212,320 | -$122,367 | -9.2% | 18 Jun 2025 |
| Jens Holstein | Director | $1,175,255 | -$423,563 | -26% | 20 Nov 2025 |
| Thomas F. Miller | Director | $796,535 | 18 Jun 2025 | ||
| David Brent Shafer | Director | $796,535 | 18 Jun 2025 | ||
| KARIN EASTHAM | Director | $631,478 | -$1,418,502 | -69% | 05 Dec 2025 |
| Jane Alley | VP, Corporate Controller | $345,020 | 17 May 2021 | ||
| KEVIN K. GORDON | Director | $231,429 | 08 Jun 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|